Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors
| Autor: | Peverelli E, Giardino E, Treppiedi D, Meregalli M, Belicchi M, Vaira V, Corbetta S, Verdelli C, Verrua E, Serban AL, Locatelli M, Carrabba G, Gaudenzi G, Malchiodi E, Cassinelli L, Lania AG, Ferrero S, Bosari S, Vitale G, Torrente Y, Spada A, Mantovani G |
|---|---|
| Přispěvatelé: | Peverelli, E, Giardino, E, Treppiedi, D, Meregalli, M, Belicchi, M, Vaira, V, Corbetta, S, Verdelli, C, Verrua, E, Serban, A, Locatelli, M, Carrabba, G, Gaudenzi, G, Malchiodi, E, Cassinelli, L, Lania, A, Ferrero, S, Bosari, S, Vitale, G, Torrente, Y, Spada, A, Mantovani, G |
| Rok vydání: | 2016 |
| Předmět: |
Adult
Male ERG1 Potassium Channel Carcinogenesis Dopamine Agents pituitary adenoma tumor stem cells somatostatin Spheroids Cellular Humans Pituitary Neoplasms dopamine drug resistance pituitary adenomas Cell Proliferation Cyclin D3 Cyclin-Dependent Kinase Inhibitor p27 DAX-1 Orphan Nuclear Receptor Drug Resistance Neoplasm Female Gene Expression Regulation Neoplastic Gonadotropins Middle Aged Neoplasm Recurrence Local Neoplastic Stem Cells RNA Splicing Factors Receptors Dopamine D2 Receptors Somatostatin |
| Zdroj: | International journal of cancer. 140(8) |
| ISSN: | 1097-0215 |
| Popis: | The role of progenitor/stem cells in pituitary tumorigenesis, resistance to pharmacological treatments and tumor recurrence is still unclear. This study investigated the presence of progenitor/stem cells in non-functioning pituitary tumors (NFPTs) and tested the efficacy of dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists to inhibit in vitro proliferation. They found that 70% of 46 NFPTs formed spheres co-expressing stem cell markers, transcription factors (DAX1, SF1, ERG1) and gonadotropins. Analysis of tumor behavior showed that spheres formation was associated with tumor invasiveness (OR = 3,96; IC: 1.05-14.88, p = 0.036). The in vitro reduction of cell proliferation by DRD2 and SSTR2 agonists (31 +/- 17% and 35 +/- 13% inhibition, respectively, p < 0.01 vs. basal) occurring in about a half of NFPTs cells was conserved in the corresponding spheres. Accordingly, these drugs increased cyclin-dependent kinase inhibitor p27 and decreased cyclin D3 expression in spheres. In conclusion, they provided further evidence for the existence of cells with a progenitor/stem cells-like phenotype in the majority of NFPTs, particularly in those with invasive behavior, and demonstrated that the antiproliferative effects of dopaminergic and somatostatinergic drugs were maintained in progenitor/stem-like cells. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text